Abstract
We present the first geographic study that uses space-time statistics to monitor COVID-19 in Brazil. The first cases of COVID-19 were confirmed in December 2019 in Wuhan, China, caused by the contamination of the SARS-CoV-2 virus, and quickly turned into a pandemic. In Brazil, the first case occurred on January 23rd, 2020 but was officially reported by the Brazilian Ministry of Health on February 25th. Since then, the number of deaths and people infected by COVID-19 in Brazil have been steadily increasing. Despite the underreporting of coronavirus cases by government agencies across the country, the State of São Paulo has the highest rate among all Brazilian States. Thus, it is essential to detect which areas contain the highest concentration of COVID-19 to implement public policies, to mitigate the spread of the epidemic. To identify these critical areas, we utilized daily confirmed case data from the Brasil.IO website between February 25th, 2020 to May 5th, 2020; which were aggregated to the municipality level. A prospective space-time scan statistic was applied to evaluate possible active clusters in three different time periods. The results visualize the space-time evolution and dynamics of COVID-19 clusters in the State of São Paulo. Since the first study period, the results highlight approximately 4.6 times the number of municipalities belonging to a significant cluster with a RR>1 on May 5th. These results can inform health authorities and public management to take the necessary measures to minimize the transmission of COVID-19 and track the evolution of significant space-time clusters.
HIGHLIGHTS
Prospective space-time statistics can improve COVID-19 surveillance in Brazil
All statistically significant clusters are located near São Paulo Municipality
There are municipalities with relative risk highest than one in the countryside
4.6 times the number of municipalities belong to a significant cluster on May 5th
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data is publicly available at https://brasil.io/dataset/covid19/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The COVID-19 case data is available at https://brasil.io/dataset/covid19/
